StockData
Vaxcyte, Inc. logo

Vaxcyte, Inc. (PCVX) stock

PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$59.40−2.21 (-3.59%)

Close on Nov 17, 2026Market cap $8.84BP/E –Yield 0.00%

Earnings

Vaxcyte's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 23, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
–
EPS, Q3 FY2026
-$1.99
-$1.56 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Vaxcyte's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 23, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 4, 2026after the close––-$1.99Release
Q2 FY2026ended Jun 30, 2026Aug 5, 2026after the close––-$1.97Release
Q1 FY2026ended Mar 31, 2026May 6, 2026after the close–––Release
Q4 FY2025ended Dec 31, 2025Feb 24, 2026after the close–––Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025after the close––-$1.56Release
Q2 FY2025ended Jun 30, 2025Aug 6, 2025after the close––-$1.22Release
Q1 FY2025ended Mar 31, 2025May 7, 2025after the close––-$1.04Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 5, 2024after the close––-$0.83Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024after the close––-$1.10Release
Q1 FY2024ended Mar 31, 2024May 8, 2024after the close––-$0.85Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Vaxcyte has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Vaxcyte puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Vaxcyte filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Update
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Results
  11. Update
  12. Update
  13. Results
  14. Results
  15. Update

See a number that looks wrong?